Please login to the form below

Not currently logged in
Email:
Password:

Mediator

This page shows the latest Mediator news and features for those working in and with pharma, biotech and healthcare.

UK Supreme Court rules in favour of Servier in NHS patent lawsuit

UK Supreme Court rules in favour of Servier in NHS patent lawsuit

drug Mediator (benfluorex) in March. ... First launched in 1976, Mediator was not taken off the market in France until 2009, several years after being withdrawn from other European countries, including Spain in 2003 and Italy in

Latest news

More from news
Approximately 1 fully matching, plus 20 partially matching documents found.

Latest Intelligence

  • Cortellis Drugs to Watch in 2020 report Cortellis Drugs to Watch in 2020 report

    of the JAK family of kinases leads to an aberrant production of pro-inflammatory mediators, which are involved in the pathogenesis of rheumatoid arthritis, and inhibition of JAK proteins is an

  • Orphan drugs and breakthrough therapies drive Cortellis Drugs to Watch 2019 Orphan drugs and breakthrough therapies drive Cortellis Drugs to Watch 2019

    Dysfunction in the regulation of the JAK family of molecules is implicated in the aberrant production of pro-inflammatory mediators that are involved in the pathogenesis of rheumatoid arthritis, and inhibition

  • Case study: From Clinical Trials to Real-World Evidence Case study: From Clinical Trials to Real-World Evidence

    on Product X’s real-world experience and heritage within dermatology and rheumatology, since these diseases share a common inflammatory mediator targeted by Product X.

  • Searching for health Searching for health

    The task of conducting the diverse themes needed for innovation is never easy and, in France, it is made even harder by the lingering echoes from the Mediator scandal.

  • Compulsory evaluation in France Compulsory evaluation in France

    The direction of travel shouldn't come as too much of a surprise, following the PIP breast implant health scare and the subsequent scandal around diabetes drug Mediator (benfluorex).

More from intelligence
Approximately 0 fully matching, plus 9 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Bedrock Healthcare Communications

Bedrock Healthcare Communications is an award-winning, independent agency founded in 2011. We partner with healthcare professionals, patients, and global pharmaceutical...

Latest intelligence

Virtual meeting technologies for reducing emissions and waste in the healthcare industry
...
Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...